A Tiny Biotech Just Posted 10× Stronger Cancer Results

Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.

Charlie Munger's Investment Wisdom: '95% Of People Have No Chance Of Beating S&P 500 Index'

Bibhu Pattnaik
March 01, 2025

The late Charlie Munger, renowned investor and vice chairman of Berkshire Hathaway (NYSE:BRK), once asserted that 95% of investors stand no chance of outperforming the S&P 500 Index.

What Happened: During an interaction a few years ago, Munger shared his thoughts on the challenges investors face in trying to outperform the market. Munger, who passed away in 2023, was a close associate of Warren Buffett, and his advice remains highly valued in the investment world.

Munger acknowledged the dominance of index funds like the S&P 500, which represents a significant portion of the market.

He warned against the risks of excessive popularity in index investing, drawing parallels to the Nifty Fifty era, where a narrow focus on a select group of stocks led to unsustainable market conditions and subsequent downturns.

“95% of people have no chance of beating the S&P 500 Index. The index funds of the S&P, it's like 75% of the market. But is there a point where index funds theoretically can't work? Of course. If everybody bought nothing but index funds, the whole world wouldn't work as people expect," Munger said.

"If you get too much faddishness in one sector or in one narrow index, of course you can get catastrophic changes like they had with the Nifty 50 in that former era," he added. "I don't see that happening when the index is three-quarters of the whole market. The problem is the whole thing can't work perfectly forever, but it will work for a long time."

Also Read: Charlie Munger’s Financial Success and Longevity Advice: ‘My Game in Life Was Always To Avoid All Standard Ways of Failing’

“One of the reasons you buy a big index like the S&P is because if you buy a small index and it gets popular, you have a self-defeating situation. When the Nifty 50 were the rage, JP Morgan talked everybody into buying just 50 stocks and they didn't care what the price was, they just bought those 50 stocks. Of course in due time, their own buying forced those 50 stocks up to 60 times earnings whereupon it broke and everything went down by like two-thirds quite fast," he added.

"I would hate to manage a trillion dollars in the big stocks and try and beat the indexes. I don't think I could do it. In fact, if you look at Berkshire, take out a hundred decisions, which is like two a year, the success of Berkshire came from two decisions a year over 50 years," Munger continued while talking about S&P.

As index investing gained popularity, Munger observed a downward trend in fees for managing large portfolios. He highlighted the challenges facing investment professionals who must adapt to a changing landscape where fee structures are increasingly competitive.

"We may have beaten the indexes, but we didn't do it by having big portfolios of securities and having subdivisions managing the drugs and subdivisions, and so the indexes are a hell of a problem for you people, but you know, why shouldn't life be hard?" he said.

Why It Matters: Munger’s insights underscore the formidable challenges inherent in trying to beat the S&P 500 Index. While index funds offer benefits such as diversification and cost-effectiveness, they also present hurdles for investors seeking to outperform the market.

The rise of index investing has led to a competitive fee environment, putting pressure on investment professionals to adapt and innovate.

Read Next

Charlie Munger's Three Investment Lessons: ';Buy Wonderful Businesses At Fair Prices, Big Money Isn't In Buying Or Selling-It's In Waiting, Good Businesses Are Ethical Businesses'

Continue Reading...

Popular

Trump Threatens Air Traffic Controllers Amid Shutdown Chaos; Pete Buttigieg Says He 'Wouldn't Last Five Minutes' in Their Job

President Donald Trump has demanded that all air traffic controllers return to work as the nation's aviation system endured another wave of mass flight cancellations, caused by staffing shortages due to the prolonged government shutdown.

First Drug to Show Breakthrough Myocarditis Data. Analysts See Potential 7-10x Upside. - Ad

This biotech just delivered a medical first in myocarditis and has a Phase 3 trial fully funded into 2027. Wall Street targets imply massive revaluation ahead.

UK leader Keir Starmer backs his Treasury chief over claims she misled the public about the economy

LONDON (AP) — British Prime Minister Keir Starmer on Monday defended his Treasury chief against opposition claims that she misled the public and the markets about the state of the public finances before .

Noem Says National Guard Shooting Suspect Was Radicalized In US

DHS Secretary Kristi Noem says that the suspect in the fatal shooting of a National Guard member in Washington was radicalized domestically.

Why Are Wall Street Insiders Moving Their Money to This One Asset? - Ad

Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.

16 Stocks To Buy If You Want To Escape The AI Hype

Bank of America is pointing investors toward 16 overlooked stocks with strong fundamentals and no direct ties to the AI boom—offering a safer path beyond the hype.

New Number One Copper Start Alert - Ad

EVs and AI devour copper. Supply cannot keep up. A Quebec discovery with high grade, infrastructure, and cheap power is funded to drill through the year. Catalysts are lining up. Institutions are circling. Move now while it is still early.

Tax-Free Student Loan Forgiveness Expires In 2026, Who Owes More Next Year?

The American Rescue Plan Act of 2021 will make most student loan forgiveness tax-free until 2025, then borrowers may owe thousands in taxes.

Bitcoin's Pullback Could Be Your Gain - Ad

More than 70 cryptos have recently outperformed Bitcoin and it's not the first time. During crypto's last bull market the top 100 coins NOT named Bitcoin went up by 174%. Now the signs show that it's happening again. This could be a chance to strike gold in some far corners of the crypto market.

Scaramucci Says This One US Mistake Helped China Become a Manufacturing Superpower

Anthony Scaramucci recently highlighted what he considers a significant error by the US that enabled China to ascend as a manufacturing superpower.

Urgent Copper Stock With Strong Catalysts - Ad

Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.

How Tyson's Chicken Business Will Offset Beef Weakness

Tyson shares rise as pricing catch-up expected to ease cost pressures; chicken strength offsets beef headwinds amid stable feed costs.

The Next 'Ozempic Moment' Could Be in Heart Disease - Ad

Just as Ozempic rewrote the obesity playbook, this breakthrough data could transform how we treat inflammatory heart disease. Fully funded. Multiple catalysts. $280B market opportunity.

Donald Trump Nullifies 92% Of Joe Biden's Autopen-Signed Documents: 'Cancelling All Executive Orders And Anything Else'

Trump moved to invalidate what he claims are most of Biden's autopen-signed actions, sparking political backlash and renewed debate over the legality and precedent of using mechanical signatures for presidential documents.

Movie Review: Time has outrun this 'Running Man'

It’s always interesting when time overtakes the dystopias of the past. In 1982 novel “The Running Man,” the United States has fallen into a totalitarian state, divided between haves and have-nots, where all movements can be surveilled and realistic video propaganda is easily generated. King’s book was set in the year 2025.

Is Big Pharma's Next Target Already in Play? - Ad

A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.

FDA's Prasad Cites Alleged Child COVID Shot Deaths in Push for Stricter Rules

FDA's new vaccine strategy tightens approval rules after internal findings linked COVID-19 shots to several child deaths.

Rand Paul Slams GOP's Shift From Fiscal Conservatism: They Voted To Add '$5 Trillion' To The Debt Ceiling — Calls It 'Decimation'

Sen. Rand Paul (R-Ky.) slammed the Republican Party for abandoning the fiscal discipline it once championed, while accusing his colleagues of embracing massive governmental deficits and greenlighting spending levels they previously opposed.

Nevada's Mining Renaissance Is Accelerating - And This Early Opportunity Is Well Positioned - Ad

Nevada's Walker Lane belt has produced 50M+ ounces of gold since the 1800s, and it's waking up again. One of the neighborhood's latest successes just secured over $6M in U.S. support and is up more than 300% YTD. Now a new early-stage explorer has moved in next door.

These are the 37 donors helping pay for Trump's $300 million White House ballroom

WASHINGTON (AP) — President Donald Trump says his $300 million White House ballroom will be paid for “100% by me and some friends of mine.”

Donald Trump Administration's Unprecedented Investment In Private Firms Raises Eyebrows

President Trump administration has invested over $10 billion of taxpayer funds in private companies deemed crucial to national security.

Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad

AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.

Analyst Sees Strong Medtronic Momentum Through 2026 With Buy Rating Intact

BofA expects Medtronic to post over 5% second-quarter revenue growth and maintain strong momentum through 2026, driven by robust procedure trends.

Air travelers face frustration as FAA's further drop in flights takes effect

Air travelers could face as busy U.S. airports need to meet a higher Federal Aviation Administration target for reducing flights Tuesday after already canceling thousands to scale back demands on the nation’s aviation system during the .

A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad

Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.

Covet an Italian masterpiece, but shy of the millions? How about a digital copy at supercar prices

MILAN (AP) — The last person to get their hands on a painting attributed to Leonardo da Vinci shelled out Now, Italian cultural officials are making it possible to purchase a limited edition, certified digital copy of the Renaissance genius’ “Lady with Disheveled Hair’’ for roughly the price of a Lamborghini.

Weekend Round-Up: Airbus Chaos, BYD's Massive Recall, Tesla's Free FSD Rides, Rivian's Tax Credit Silver Lining And More

From emergency aircraft recalls to massive vehicle recalls in China, to free self-driving rides in Europe, the past week was buzzing in the auto and tech sector.

First Drug to Show Breakthrough Myocarditis Data. Analysts See Potential 7-10x Upside. - Ad

This biotech just delivered a medical first in myocarditis and has a Phase 3 trial fully funded into 2027. Wall Street targets imply massive revaluation ahead.

The Key to a Winning 401(k)

: when to start, how much to save, and where to invest. The investing decision has drawn more attention as government regulators work to open 401(k) plans to alternative assets such as .

Why Are Wall Street Insiders Moving Their Money to This One Asset? - Ad

Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.

Gen Z Takes To 'Income Stacking' As One Pay Check Falls Short

Gen Zers are turning to income stacking to secure their financial future as they fear a single paycheck won't be enough. AI and broken social contract fuel the shift. Side hustles becoming core of young careers.

New Number One Copper Start Alert - Ad

EVs and AI devour copper. Supply cannot keep up. A Quebec discovery with high grade, infrastructure, and cheap power is funded to drill through the year. Catalysts are lining up. Institutions are circling. Move now while it is still early.

JPMorgan Forecasts Bitcoin Bottom, Anticipates $28.3 Trillion Challenge To Gold By 2026

Analysts at JPMorgan have pinpointed the lowest point of the ongoing Bitcoin (CRYPTO: BTC) price fall and also projected a substantial chall

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service